Wegovy GoodRx, NovoCare $299, Costco $349, Sam's Club: Every GLP-1 Cash-Pay Coupon & Channel (2026)

Cash-pay GLP-1 pricing changed dramatically in 2025-2026. NovoCare repriced Wegovy from $499 to $299/month. LillyDirect launched the Self Pay Journey Program for Zepbound vials at $299-$449/month. Sam's Club launched oral Wegovy at $149/month with free same-day refrigerated delivery for Plus members. Costco offers Wegovy + Ozempic at $349/month via the Sesame partner. Amazon Pharmacy launched Foundayo at $149/month with same-day delivery in 3,000+ cities. Every channel, every drug, every verified 2026 price below.

Quick reference: cheapest cash-pay path by drug

NovoCare Pharmacy (Wegovy + Ozempic, Novo Nordisk)

NovoCare is Novo Nordisk's direct-to-consumer self-pay pharmacy for Wegovy and Ozempic. The platform launched at $499/month for Wegovy in early 2025 — the headline that drove most of the press coverage at the time. As of the verified 2026-05-09 fetch, those prices have come down significantly:

• Wegovy standard pen (0.25-2.4 mg): $299/month
• Wegovy oral pill (1.5 mg, 4 mg): $149/month (promotional pricing through August 31, 2026, then $199/mo for the 4 mg dose)
• Wegovy HD pen 7.2 mg: $399/month
• Wegovy new patient promotion: $199/month for the first 2 months of treatment on the lowest two doses (0.25 mg + 0.5 mg) — through June 30, 2026
• Wegovy with insurance copay savings card: as little as $25/month with maximum savings of $100/month
• Ozempic standard pen: $199/month for new patients (first 2 months); $349/month standard self-pay
• Ozempic with insurance copay card: as little as $25/month for up to 3 months

Eligibility: the NovoCare self-pay path is for “uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity medicines.” Government beneficiaries (Medicare, Medicaid, VA, TRICARE) are excluded from the $25 copay offer per Novo Nordisk policy.

LillyDirect (Zepbound, Mounjaro, Foundayo, Eli Lilly)

LillyDirect is Eli Lilly's DTC platform for self-pay access to its weight-management and diabetes products. The Self Pay Journey Program for Zepbound vials launched December 1, 2025 with the verbatim verified pricing:

• Zepbound 2.5 mg vial: $299/month (a $50 price reduction from launch)
• Zepbound 5 mg vial: $399/month (a $100 reduction)
• Zepbound 7.5 / 10 / 12.5 / 15 mg vials: $449/month (from the original $499)
• Zepbound KwikPen: $299–$699 by strength (higher than vials)
• Foundayo (orforglipron): $149/month at launch
• Mounjaro: NOT in the LillyDirect Self Pay Journey Program — the only Mounjaro cash-pay path is via the Mounjaro Savings Card for commercially insured patients

Eligibility: “self-paying patients using LillyDirect” with “a valid prescription.” See our Mounjaro vs Zepbound complete comparison for the dual-brand context — Mounjaro and Zepbound are the same molecule, but only Zepbound has the LillyDirect self-pay path.

Costco Member Prescription Program (CMPP) via Sesame

Costco launched the Member Prescription Program partnership with Sesame for GLP-1 access in early 2026. The program offers Wegovy and Ozempic at $349/month — the first true retailer-discount tier below the manufacturer's NovoCare floor — via a Sesame-managed prescriber and Costco-pharmacy fulfillment. Verified pricing:

• Wegovy / Ozempic standard: $349/month
• New patient promotion: $199/month for the first 2 months on the lowest two doses
• Wegovy 4 mg pill: $149/month through August 31, 2026, then $199/month
• Eligibility: “Any Costco Member can join CMPP.” Membership-gated for the discount tier; non-members can fill Rx at posted cash price by federal pharmacy access law (but cannot use the CMPP discount).
• Exclusions: “CMPP is not insurance … Claims submitted for coverage under publicly funded programs (Medicare, Medicaid, etc.) or private insurance are not eligible for CMPP participation.”
• Zepbound: Costco CMPP page exists for Zepbound but no Lilly partnership equivalent to the Novo $349 deal — Zepbound dispensed at LillyDirect-equivalent self-pay tier.

Sam's Club Plus Pharmacy

Sam's Club's GLP-1 program is the most aggressive retail-channel offering as of 2026. Two distinct paths:

• Oral Wegovy (1.5 mg) at $149/month — launched January 7, 2026 via the manufacturer's self-pay offer
• Wegovy + Ozempic injection pens at $499/month — through the Novo Nordisk Copay Savings Program for eligible Sam's Club members (commercial insurance without coverage; uninsured)
• Zepbound KwikPen by strength: $299 (2.5 mg) / $399 (5 mg) / $499 (7.5 mg) / $699 (10/12.5/15 mg)
• Free same-day refrigerated delivery for Plus members when ordered by 2 p.m. (Club and non-members pay $12)
• Eligibility for manufacturer copay programs: gated by Novo Nordisk and Eli Lilly eligibility criteria (uninsured / commercial without coverage; government beneficiaries excluded)

Amazon Pharmacy (Foundayo same-day delivery)

Amazon Pharmacy launched Foundayo (orforglipron) on April 9, 2026 — eight days after FDA approval. Verified pricing:

• Insured price: “starts as low as $1 per day or $25 per month”
• Cash price: “$5 per day or $149 per month”
• Manufacturer-sponsored coupons are applied automatically before checkout
• Same-day delivery: “in nearly 3,000 cities and towns, expanding to nearly 4,500 by year end”
• Pharmacist-supported kiosks at select One Medical locations for in-office pickup immediately after medical appointments

GoodRx coupon path for every GLP-1

GoodRx aggregates manufacturer-funded coupons for GLP-1 medications across its 70,000+ network pharmacies. Verified cheapest cash prices via GoodRx as of 2026-05-09:

• Wegovy oral pill 1.5 mg: $149.00 through April 15, 2026 (manufacturer-funded; $199 for 4 mg post April 15)
• Wegovy injection pen: ~$1,300+ retail with a 9–24% coupon (the GoodRx headline price for Wegovy isn't the cheapest path — NovoCare $299 wins)
• Ozempic: $149.00 low (oral 1.5 mg); injection pen via Novo $199 first 2 fills then $349
• Zepbound: $299/month for KwikPen via manufacturer offer; $995 retail for vials/pen without coupon
• Mounjaro: ~$995 at the cheapest pharmacy — the only GLP-1 with no DTC discount path
• Foundayo: $149.00 cash; $25 with manufacturer coupon for 30-tab 0.8 mg

Important: GoodRx coupons cannot stack with insurance — using a GoodRx coupon means paying cash and forgoing your insurance copay. Manufacturer-funded GoodRx prices (Wegovy oral pill, Foundayo, Zepbound KwikPen) require eligibility for the brand's underlying self-pay program.

Channels NOT carrying brand-name GLP-1s in 2026

• Cost Plus Drugs (Mark Cuban): 0 brand-name GLP-1 SKUs as of 2026-05-09. Per Mark Cuban directly: “Our mission is to sell any FDA approved drug. Right now the manufacturer won't sell through us.” The April 2026 9amHealth partnership covers oral weight-management adjuncts only — branded GLP-1s are not available at MCCPDC.
• Walmart Pharmacy has no Walmart-specific national cash price for branded GLP-1s — accepts NovoCare ($299–$499) and LillyDirect ($299–$449) self-pay vouchers per the October 2025 LillyDirect-at-Walmart pickup deal. Walmart+ Rx generic formulary does NOT include branded GLP-1s.

HSA / FSA eligibility

Brand-name and compounded GLP-1s are generally HSA/FSA eligible as a medical expense with a valid prescription per IRS Publication 502. This applies regardless of cash-pay channel — NovoCare, LillyDirect, Costco, Sam's Club, Amazon Pharmacy, and GoodRx coupon purchases can all be paid from your HSA/FSA debit card. Compounded GLP-1s from licensed 503A pharmacies are also typically eligible with a prescription, though some plan administrators require a Letter of Medical Necessity. See our insurance coverage hub for the broader payer landscape.

Verification log

Every price above was verified live on 2026-05-09 by direct fetch from the source channel. Where the channel page returned 403 to automated fetch (Costco, GoodRx, Walmart product pages), pricing was sourced from the partner page (Sesame for Costco), corporate press release (Walmart corporate newsroom for Sam's Club, Amazon press for Foundayo, Lilly investor relations for LillyDirect Zepbound, Novo PR Newswire for NovoCare launch), or industry primary publication (PharmExec for Lilly investor release verbatim). The historical NovoCare $499 launch price has been replaced by the current $299/month standard pen — DO NOT cite the older figure.

For the live channel-by-channel pricing across every brand plus compounded options, see our GLP-1 pricing index which is refreshed monthly.